AU1415099A - 4-substituted-4-piperidine carboxamide derivatives - Google Patents

4-substituted-4-piperidine carboxamide derivatives

Info

Publication number
AU1415099A
AU1415099A AU14150/99A AU1415099A AU1415099A AU 1415099 A AU1415099 A AU 1415099A AU 14150/99 A AU14150/99 A AU 14150/99A AU 1415099 A AU1415099 A AU 1415099A AU 1415099 A AU1415099 A AU 1415099A
Authority
AU
Australia
Prior art keywords
substituted
carboxamide derivatives
piperidine carboxamide
piperidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14150/99A
Inventor
William K. Hagmann
Stephen E. De Laszlo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9727214.0A external-priority patent/GB9727214D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU1415099A publication Critical patent/AU1415099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU14150/99A 1997-11-18 1998-11-16 4-substituted-4-piperidine carboxamide derivatives Abandoned AU1415099A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6591797P 1997-11-18 1997-11-18
US60065917 1997-11-18
GB9727214 1997-12-23
GBGB9727214.0A GB9727214D0 (en) 1997-12-23 1997-12-23 4-Substituted-4-piperdine carboxamide derivatives
PCT/US1998/024513 WO1999025685A1 (en) 1997-11-18 1998-11-16 4-substituted-4-piperidine carboxamide derivatives

Publications (1)

Publication Number Publication Date
AU1415099A true AU1415099A (en) 1999-06-07

Family

ID=26312836

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14150/99A Abandoned AU1415099A (en) 1997-11-18 1998-11-16 4-substituted-4-piperidine carboxamide derivatives

Country Status (2)

Country Link
AU (1) AU1415099A (en)
WO (1) WO1999025685A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1156807A4 (en) * 1998-12-18 2002-04-03 Du Pont Pharm Co N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
CZ20011872A3 (en) 1999-09-29 2002-03-13 Ortho-Mcneil Pharmaceutical, Inc. Isonipecotamides for the treatment of integrin-mediated disorders
DE19962936A1 (en) 1999-12-24 2001-06-28 Bayer Ag New beta-aminoacid amide derivatives, are integrin antagonists useful for treating inflammatory, autoimmune or immunological disorders e.g. asthma, diabetes or rheumatoid arthritis
PL357109A1 (en) 1999-12-28 2004-07-12 Pfizer Products Inc. Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
CZ20032258A3 (en) 2001-02-23 2004-01-14 Merck & Co., Inc. N-substituted non-aryl heterocyclic compounds
DE60208186T2 (en) 2001-04-09 2006-08-24 Ortho-Mcneil Pharmaceutical Research Inc. CHINAZOLIN AND CHINAZOLE-RELATED COMPOUNDS FOR THE TREATMENT OF INTEGRIN-MEDIATED DISEASES
TW200403058A (en) * 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
JP4617449B2 (en) 2002-07-11 2011-01-26 ヴィキュロン ファーマシューティカルズ インコーポレイテッド N-hydroxyamide derivative having antibacterial activity
GB0310724D0 (en) * 2003-05-09 2003-06-11 Glaxo Group Ltd Chemical compounds
WO2005016883A2 (en) * 2003-08-14 2005-02-24 Icos Corporation Acrylamide derivatives as vla-1 integrin antagonists and uses thereof
GB0412865D0 (en) 2004-06-09 2004-07-14 Glaxo Group Ltd Chemical compounds
TW200610754A (en) * 2004-06-14 2006-04-01 Daiichi Seiyaku Co Vla-4 inhibitor
WO2008103378A2 (en) 2007-02-20 2008-08-28 Merrimack Pharmaceuticals, Inc. Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
PL2288715T3 (en) 2008-04-11 2015-03-31 Merrimack Pharmaceuticals Inc Human serum albumin linkers and conjugates thereof
CN104356051A (en) * 2014-11-24 2015-02-18 苏州乔纳森新材料科技有限公司 Analgesic intermediate and synthesis method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL90218A0 (en) * 1988-05-13 1989-12-15 Abbott Lab Retroviral protease inhibitors
RU2161155C2 (en) * 1993-09-22 2000-12-27 Фудзисава Фармасьютикал Ко., Лтд Derivatives of n-(3-piperidinylcarbonyl)-beta-alanine as antagonists of platelet activation factor, method of synthesis, pharmaceutical composition and method of treatment
US5770575A (en) * 1994-03-16 1998-06-23 Ortho Pharmaceutical Corporation Nipecotic acid derivatives as antithrombotic compounds
US6248713B1 (en) * 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors

Also Published As

Publication number Publication date
WO1999025685A1 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
AU1411499A (en) Para-aminomethylaryl carboxamide derivatives
AU1151099A (en) Azaoxindole derivatives
AU1825899A (en) Dota-biotin derivatives
AU7552198A (en) Benzylamine derivatives
AU7935398A (en) Diaminorhodamine derivatives
AU6117998A (en) 3-oxadiazolylquinoxaline derivatives
AUPO395396A0 (en) Benzamide derivatives
AU4383397A (en) Hetaroyl derivatives
AU4554297A (en) Hetaroyl derivatives
AU1735497A (en) Sulfonylureidopyrazole derivatives
AU3867997A (en) Chromene-3-carboxylate derivatives
AU2956097A (en) Alkylaminobenzothiazole and -benzoxazole derivatives
AU1415099A (en) 4-substituted-4-piperidine carboxamide derivatives
EP1008579A3 (en) Cyclopentenebutanol derivatives
AU7813598A (en) Betulinol derivatives
AU7474998A (en) Haloisoquinoline carboxamide
AU4962097A (en) 2-methoxyphenylpiperazine derivatives
AU6729498A (en) Thiazolimine derivatives
AU1174199A (en) Biphenylamidine derivatives
AUPO863197A0 (en) Novel derivatives
AU1793197A (en) Pyrazole-4-yl-hetaroyl derivatives
AU3685097A (en) N-benzylazolium derivatives
AUPO565997A0 (en) Propanolamine derivatives
AU6115798A (en) Saponarin derivatives
AU1562199A (en) Amino-benzothiazole derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase